A
Arindam Bhattacharyya
Researcher at University of Calcutta
Publications - 85
Citations - 1924
Arindam Bhattacharyya is an academic researcher from University of Calcutta. The author has contributed to research in topics: Immune system & Apoptosis. The author has an hindex of 21, co-authored 79 publications receiving 1345 citations. Previous affiliations of Arindam Bhattacharyya include Kalyani Government Engineering College.
Papers
More filters
Journal ArticleDOI
Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound.
Loganathan Karthik,Gaurav Kumar,Tarun Keswani,Arindam Bhattacharyya,S. Sarath Chandar,K.V. Bhaskara Rao +5 more
TL;DR: The results obtained infer that the peptide from Streptomyces sp LK3 extract possesses anti- Pf activity activity, suggesting that the extracts have novel metabolites and could be considered as a potential source for drug development.
Journal ArticleDOI
Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer.
Subir Biswas,Gunjan Mandal,Sougata Roy Chowdhury,Suman Purohit,Kyle K. Payne,Carmen M. Anadon,Arnab Gupta,Patricia Swanson,Xiaoqing Yu,Jose R. Conejo-Garcia,Arindam Bhattacharyya +10 more
TL;DR: It is demonstrated that exosomes secreted by human and mouse tumor-educated mesenchymal stem cells drive accelerated breast cancer progression by inducing differentiation of monocytic myeloid-derived suppressor cells into highly immunosuppressive M2-polarized macrophages at tumor beds.
Journal ArticleDOI
CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Subir Biswas,Suman Sengupta,Sougata Roy Chowdhury,Samir Jana,Gunjan Mandal,Palash Kumar Mandal,Nipun Saha,Vivek Malhotra,Arnab Gupta,Dmitry V. Kuprash,Arindam Bhattacharyya +10 more
TL;DR: The EMT-inducing potential of CXCL13 is shown as well as the prognostic value of C XCL13–CXCR5 co-expression in primary BC is demonstrated, suggesting that CxCL13-CX CR5–RANKL–Src axis may present a therapeutic target in LNM positive BC patients.
Journal ArticleDOI
Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach.
Subhadip Kundu,Suman Sengupta,Soumya Chatterjee,Soham Mitra,Arindam Bhattacharyya,Arindam Bhattacharyya +5 more
TL;DR: The results prove that cadmium causes both inflammation and cell proliferation when applied in a low dose but proliferative changes occur independent of inflammation.
Journal ArticleDOI
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
Samuel M. Meier,Dominique Kreutz,Lilli Winter,Matthias H. M. Klose,Klaudia Cseh,Tamara Weiss,Andrea Bileck,Beatrix Alte,Johanna C. Mader,Samir Jana,Annesha Chatterjee,Arindam Bhattacharyya,Michaela Hejl,Michael A. Jakupec,Petra Heffeter,Walter Berger,Christian G. Hartinger,Bernhard K. Keppler,Gerhard Wiche,Christopher Gerner +19 more
TL;DR: Plectin targeting shows potential as a strategy to inhibit tumor invasiveness as shown in cultured tumor spheroids while oral administration of plecstatin-1 to mice reduces tumor growth more efficiently in the invasive B16 melanoma than in the CT26 colon tumor model.